Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:53 AM UTC
| NCT Number | NCT05243797 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 1,594 participants |
| Active Locations | 42 sites in the US |
| Sponsor | Stichting European Myeloma Network |
| Last Updated on CT.gov | June 4, 2026 (Jun 4, 2026) |
As of July 18, 2026: Clinical trial NCT05243797 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 42 locations across the United States. The study is sponsored by Stichting European Myeloma Network. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05243797 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 42 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05243797 was last updated Jun 4, 2026 (June 4, 2026). HelloStudys verifies this status automatically.